BiopSense

BiopSense is a molecular diagnostics company focusing on cell-free DNA (cfDNA) processing from liquid biopsy samples. cfDNA has a high clinical significance for the diagnosis, monitoring, and detection of various diseases, such as cancer, prenatal testing, transplantation, and cardiovascular conditions. Reliable methods are, however, required to isolate and quantify the scarce cfDNA with high sensitivity, and its transportation logistics are complex, too. BiopSense has developed a novel point-of-care automated blood sample processing solution for quick, high-quality cfDNA extraction and stabilization for further transportation and off-site analysis. BiopSense technology is composed of a measurement device and single-use cartridges where the sample is placed. This solution will improve access to liquid biopsy diagnostics, unblocking the global growth of the cfDNA-based molecular diagnostics market.